Drug recall · March 23, 2016
NABUMETONE Tablets USP recall
Why: Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL
- Lots / codes
Lot #: 05N533, Exp 11/16
- Quantity
- 576 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- November 19, 2015 · Voluntary: Firm initiated
- Classified
- March 11, 2016
- Reported
- March 23, 2016
- Ended
- November 15, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nabumetone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.